Pyrrolopyridines as kinase inhibitors

Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pat...

Full description

Saved in:
Bibliographic Details
Main Authors Lyon, Michael, Mohr, Peter J, Blake, James F, Wang, Bin, Chicarelli, Mark Joseph, Le Huerou, Yvan, Gunawardana, Indrani W, Wallace, Eli M
Format Patent
LanguageEnglish
Published 15.05.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Bibliography:Application Number: US201614988521